Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study.
Janiri
Luigi
L
Martinotti
Giovanni
G
Di Nicola
Marco
M
D000328:Adult; D000427:Alcohol Deterrents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000428:Alcohol Drinking / Q000188:drug therapy; D000437:Alcoholism / Q000188:drug therapy*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D016739:Behavior, Addictive / Q000188:drug therapy; D017831:Diagnosis, Dual (Psychiatry); D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000523:psychology; D010865:Pilot Projects; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D055502:Secondary Prevention; D013695:Temperance
D000427:Alcohol Deterrents; D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole